Oppenheimer & Co
AZR icon

Oppenheimer & Co’s Azora Therapeutics, Inc. Common Stock AZR Stock Holding History

Oppenheimer & Co’s Portfolio AZR Stock Details AZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-62
Closed -$13K – 1349
2022
Q3 		$13K Hold
62
– – ﹤0.01% 1350
2022
Q2 		$52K Hold
62
– – ﹤0.01% 1362
2022
Q1 		$77K Hold
62
– – ﹤0.01% 1421
2021
Q4 		$104K Hold
62
– – ﹤0.01% 1444
2021
Q3 		$165K Buy
62
+17
+38% +$35.6K ﹤0.01% 1417
2021
Q2 		$71K Buy
45
+22
+96% +$33.5K ﹤0.01% 1479
2021
Q1 		$35K Buy
+23
New +$34.8K ﹤0.01% 1424

Other funds holding AZR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Virtu Financial
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Raffa Wealth Management
Raffa Wealth Management Washington, District of Columbia $793M AUM 13.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Oppenheimer & Co's AZR Position: Q4 2022 in Review

Oppenheimer & Co sold out of Azora Therapeutics, Inc. Common Stock (AZR) in Q4 2022, closing a stake of 62 shares — an estimated $13K sold.

Oppenheimer & Co first reported a position in AZR in Q1 2021 and held it in 7 quarters. The position peaked at $165K in Q3 2021. 21 funds tracked by Wall St. Rank hold AZR as of Q4 2022.

  • Oppenheimer & Co reported no remaining Azora Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Oppenheimer & Co sold 62 Azora Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $13K.
  • Oppenheimer & Co first reported a position in Azora Therapeutics, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
  • Oppenheimer & Co's Azora Therapeutics, Inc. Common Stock position peaked at $165K in Q3 2021.
  • 21 funds tracked by Wall St. Rank held Azora Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Oppenheimer & Co's 13F filing for Q4 2022, filed 8 Feb 2023.